Theratechnologies
(NASDAQ) THTX
This security has been delisted. This page is retained for historical reference.
THTX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowTHTX Financials
Key Financial Metrics (TTM)
Gross Margin
77.75%
Operating Margin
-0.02%
Net Income Margin
-11.81%
Return on Equity
16.59%
Return on Capital
40.20%
Return on Assets
-8.47%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
N/A
Volume
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$65.58M
Operating Income
$7.12M
EBITDA
$2.34M
Operating Cash Flow
$7.04M
Capital Expenditure
-$10.11M
Free Cash Flow
-$3.08M
Cash & ST Invst.
$9.92M
Total Debt
$43.62M
Theratechnologies Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$17.73M
-19.5%
Gross Profit
$13.03M
-25.4%
Gross Margin
73.50%
N/A
Market Cap
N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
N/A
N/A
Employees
103
N/A
Net Income
-$4.46M
-552.1%
EBITDA
-$2.64M
-152.9%
Quarterly Fundamentals
Total Cash
$9.92M
-72.5%
Total Debt
$43.62M
-26.5%
Accounts Receivable
$11.37M
-11.5%
Inventory
$7.62M
+37.6%
Long Term Debt
$39.99M
-3.5%
Short Term Debt
$3.63M
-79.7%
Return on Assets
-8.47%
N/A
Return on Invested Capital
-0.07%
N/A
Free Cash Flow
$12.40M
+792.5%
Operating Cash Flow
$12.40M
+4376.9%